Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Recro Pharma Inc (NQ: REPH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 21, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.600 (2) Ask (Size) 2.300 (3) Prev. Close 2.090 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 90,127,280 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Recro Pharma Earnings Perspective: Return On Capital Employed March 07, 2022 According to data from Benzinga Pro, during Q4, Recro Pharma's (NASDAQ:REPH) reported sales totaled $22.30 million. Despite a 32.39% increase in earnings, the company posted a... Via Benzinga Recap: Recro Pharma Q4 Earnings March 01, 2022 Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Recro... Via Benzinga Performance More News Read More Earnings Scheduled For March 1, 2022 March 01, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 12, 2022 Via Benzinga 5 Penny Stocks Insiders Are Buying November 16, 2021 Via Benzinga Recro Secures Manufacturing Contract From NIH For Nasal Spray Analgesic October 20, 2021 Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Via Benzinga Exposures Product Safety Earnings Scheduled For May 6, 2021 May 06, 2021 Via Benzinga The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data November 09, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021 October 12, 2021 Via Benzinga Recro Pharma's Return On Capital Employed Overview September 16, 2021 Via Benzinga Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder September 08, 2021 Via NewMediaWire Exposures COVID-19 Product Safety 12 Health Care Stocks Moving In Wednesday's After-Market Session September 01, 2021 Via Benzinga 60 Biggest Movers From Yesterday August 17, 2021 Via Benzinga 38 Stocks Moving In Monday's Mid-Day Session August 16, 2021 Via Benzinga 78 Biggest Movers From Friday August 16, 2021 Via Benzinga Recro Pharma: Q2 Earnings Insights August 09, 2021 Via Benzinga Earnings Scheduled For August 9, 2021 August 09, 2021 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 12, 2021 Via Benzinga 70 Biggest Movers From Friday May 10, 2021 Via Benzinga 56 Stocks Moving In Friday's Mid-Day Session May 07, 2021 Via Benzinga Earnings Preview for Recro Pharma May 05, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.